Lupus Nephritis: The CASE for Early Recognition and Management
A non-promotional spotlight supported by GSK discussing the importance of recognizing lupus nephritis promptly and managing to complete response. Chair Dr. Brad Rovin will open with an introduction to lupus nephritis as the most serious common manifestation of systemic lupus erythematosus (SLE). This will be followed by the exploration of lupus nephritis management via patient case studies provided by Dr. Maria Dall'Era and Dr. Jonathan Hogan.
Maria Dall'Era, MD Lupus Clinic and Rheumatology Clinical Research Center, University of California, San Francisco
Dr. Maria Dall'Era is the Jean S. Engleman Distinguished Professor and Chief of the Division of Rheumatology at UCSF. She is the Director of the UCSF Lupus Center and the Rheumatology Clinical Research Center.
Maria leads an integrated research program focused on three closely related goals: (i) improving our understanding of the molecular and epidemiologic basis for SLE, (ii) developing novel approaches to the treatment of SLE and lupus nephritis, and (iii) finding biomarkers that predict treatment response and long-term outcome in patients with lupus nephritis. She is currently the protocol chair of two NIH-funded clinical trials in lupus nephritis and is the PI of a CDC-funded longitudinal lupus cohort of patients throughout the San Francisco Bay Area. She holds several national leadership positions, including vice-chair of the Steering Committee of the Lupus Clinical Investigators Network and co-chair of the Steering Committee of the Lupus Nephritis Trials Network. She received the Edmund L. Dubois Memorial Lectureship Award from the American College of Rheumatology and the Ephraim Engleman Award for Excellence in Arthritis Research.
In the UCSF Lupus Clinic, Maria cares for > 200 patients with SLE from throughout Northern California. She supervises medical students, medical residents, and rheumatology fellows who train with her in the clinic.
Jonathan Hogan, MD Perelman School of Medicine, University of Pennsylvania
Dr. Jonathan Hogan is an Assistant Professor of Medicine, Division of Nephrology, at the Perelman School of Medicine, University of Pennsylvania, in Philadelphia, PA. He is the clinical director of the Penn Glomerular Disease Center and also runs the Penn Onconephrology Program. He is site-PI on multiple industry and NIH-sponsored trials and studies in glomerular diseases and diabetic nephropathy. He has published multiple peer-reviewed manuscripts and book chapters on glomerular diseases and onconephrology, and has been an invited speaker on these topics at regional, national and international meetings.
Dr. Hogan was born and raised in Queens, New York. He received Bachelors Degrees in Philosophy and Biology at Fordham University in the Bronx, New York. He received his medical degree from the University of Pennsylvania in Philadelphia, PA, and completed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania. He then completed his fellowship in Nephrology at Columbia University Medical Center, and a subspecialty fellowship in Glomerular Diseases at the Columbia University Glomerular Center.
Brad Rovin, MD, FACP, FASN The Ohio State University Wexner Medical Center
Dr. Brad H. Rovin is the Lee A. Hebert Professor of Nephrology. Dr. Rovin received his Bachelor of Science in Chemical Engineering from Northwestern University in Evanston Illinois and his Doctor of Medicine from the University of Illinois Medical School in Chicago. He completed a residency in Internal Medicine at Barnes Hospital in St. Louis Missouri, and a Fellowship in Nephrology at Washington University School of Medicine. He joined the College of Medicine Faculty in 1990, became Director of the Division of Nephrology in 2004 and served as Vice Chairman of Medicine for Research from 2009–2019. In 2019 he became the Medical Director of the Ohio State University Clinical Research Management Institute.
Dr. Rovin has had several leadership roles in the American Society of Nephrology, including running the Glomerular Diseases Pre-Course and Co-Editing NephSAP-Glomerular Diseases. Most recently he was appointed Deputy Editor of Kidney International, the flagship journal of the International Society of Nephrology. He is also Co-Chair for glomerular disease guideline development for the Kidney Disease Improving Global Outcomes effort.
Dr. Rovin studies the immunopathogenesis of glomerular and autoimmune diseases. He is a founding member of NephroNet, a grass-roots nephrology community clinical trial organization, and the Lupus Nephritis Clinical Trials Network. He is and has been the Principal Investigator on several trials of novel therapeutics for glomerular diseases.